Results 11 to 20 of about 4,801,388 (251)

Investigating the impact of NHS based ovarian cancer screening [PDF]

, 2010
the UK ovarian cancer is the fifth most common cancer in females and after uterine cancer, the second most common gynaecological cancer. There were 6,596 new cases diagnosed in the UK in 2006.
Nicholson, S. M.
core   +7 more sources

Research Progress of Estrogen Receptor in Ovarian Cancer

Clinical and Experimental Obstetrics & Gynecology, 2023
Objective: This review aims to provide some theoretical guidance for the precise treatment of ovarian cancer and the development of estrogen-related drugs.
Mengchen Zhang, Haohui Xu, Yixin Zhang, Zhanfei Li, Wenqiang Meng, Jiayi Xia, Wentao Lei, Kai Meng, Yan Guo   +8 more
doaj   +1 more source

Molecular mechanisms of ovarian cancer prevention [PDF]

, 2023
Combined oral contraceptive pill (COCP) lowers the risk of ovarian cancer. The risk reduction has been reported as between 33 - 41%. The duration of use affects the risk reduction. The mechanism of risk reduction has been theorised.
Koo, Chail
core   +1 more source

Maternal pelvic size not predictive of daughter's breast cancer or ovarian cancer in a large Swedish cohort. [PDF]

, 2009
Recent studies from Finland reported that maternal pelvic size predicted daughters' breast and ovarian cancer, possibly because maternal pelvic size is a marker for in utero hormone exposure.
Goodman, Anna, Silva, Isabel dos Santos, Silva Idos, S., Mishra, G.D., Koupil, Ilona,, Mishra, Gita D, Koupil, Ilona, Silva, Isabel D., Mishra, Gita D.   +8 more
core   +1 more source

Animal models of ovarian cancer. [PDF]

, 2003
Ovarian cancer is the most lethal of all of the gynecological cancers and can arise from any cell type of the ovary, including germ cells, granulosa or stromal cells.
Jean-François Ethier, Vanderhyden Barbara C, Shaw, TJ, Ethier Jean-François, Vanderhyden, BC, Shaw, Tanya J, Ethier, JF, Tanya J Shaw, Shaw Tanya J, Vanderhyden, Barbara C, Ethier, Jean-François, Barbara C Vanderhyden   +11 more
core   +1 more source

Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers – an interventional randomized controlled multicenter trial (LIBRE-1)

BMC Cancer, 2017
Background Women with pathogenic BRCA germline mutations have an increased risk for breast and ovarian cancer that seems to be modified by life-style factors.
Marion Kiechle, Ricarda Dukatz, Maryam Yahiaoui-Doktor, Anika Berling, Maryam Basrai, Vera Staiger, Uwe Niederberger, Nicole Marter, Jacqueline Lammert, Sabine Grill, Katharina Pfeifer, Kerstin Rhiem, Rita K. Schmutzler, Matthias Laudes, Michael Siniatchkin, Martin Halle, Stephan C. Bischoff, Christoph Engel   +17 more
doaj   +1 more source

Incomplete pregnancy and risk of ovarian cancer: Results from two Australian case–control studies and systematic review [PDF]

, 2009
Although full-term pregnancies reduce the risk of ovarian cancer, it has not been conclusively established whether incomplete pregnancies also influence risk.
Dick, Marie-Louise B., Purdie, David M., Dick, Marie Louise B, Green, Adele C., The Australian Ovarian Cancer Study Group, Siskind, Vic, Siskind, Victor, Australian Cancer Study Group (Ovarian Group), Vic Siskind, David M. Purdie, null null, Adèle C. Green, Marie-Louise B. Dick   +12 more
core   +1 more source

Tertiary Prevention of Ovarian Cancer After PARP Inhibitor Therapy

Zhongliu Fangzhi Yanjiu, 2023
The tertiary prevention approaches of ovarian cancer include whole-person care, training of the patients to cooperate with physicians in the periods of treatment and follow-up, training program of the qualified surgeons, and recognition of biological ...
ZANG Rongyu
doaj   +1 more source

Investigating the potential for expediting diagnosis of ovarian cancer via prompt symptom recognition & "targeted screening" [PDF]

, 2009
PhDThis thesis explores the potential for using symptoms as a tool to bring forward the diagnosis of ovarian cancer. Current evidence supports the existence of prediagnostic symptoms, however symptom lead time has yet to be adequately quantified ...
Lim, Anita Wey Wey
core   +2 more sources

Research Progress of MicroRNA in Early Detection of Ovarian Cancer

Chinese Medical Journal, 2015
Objective: This review aimed to update the progress of microRNA (miRNA) in early detection of ovarian cancer. We discussed the current clinical diagnosis methods and biomarkers of ovarian cancer, especially the methods of miRNA in early detection of ...
Ze-Hua Wang, Cong-Jian Xu
doaj   +1 more source